COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience

The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), identified in late 2019 as the causative agent of COVID-19, was declared a pandemic by the World Health Organization on 11 March 2020. Widespread community transmission in the United States triggered a nationwide shu...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Blood Adv
Main Authors: Maurer, Katie, Saucier, Anna, Kim, Haesook T., Acharya, Utkarsh, Mo, Clifton C., Porter, Julie, Albert, Cindy, Cutler, Corey, Antin, Joseph H., Koreth, John, Gooptu, Mahasweta, Romee, Rizwan, Wu, Catherine J., Soiffer, Robert J., Nikiforow, Sarah, Jacobson, Caron, Ho, Vincent T.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Hematology 2021
נושאים:
Transplantation
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869610/
https://ncbi.nlm.nih.gov/pubmed/33560397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003883
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים